Diagnostic Efficacy of 24-hr Esophageal pH Monitoring in Patients with Refractory Gastroesophageal Reflux Disease by Gharib, Atoosa et al.
 
Open Access Maced J Med Sci electronic publication ahead of print,  
published on July 09, 2018 as https://doi.org/10.3889/oamjms.2018.268 
_______________________________________________________________________________________________________________________________ 
Open Access Maced J Med Sci.                                                                                                                                                                                                          1 
 
ID Design Press, Skopje, Republic of Macedonia 
Open Access Macedonian Journal of Medical Sciences. 
https://doi.org/10.3889/oamjms.2018.268 
eISSN: 1857-9655 
Clinical Science 
 
 
  
 
Diagnostic Efficacy of 24-hr Esophageal pH Monitoring in 
Patients with Refractory Gastroesophageal Reflux Disease 
 
 
Atoosa Gharib
1
, Mojgan Forootan
2*
, Marjan Sharifzadeh
3
, Saied Abdi
4
, Mohammad Darvishi
5
, Ahmad Eghbali
6
 
 
1
Shahid Modarres Clinical Research and Development Center, Shahid Beheshti University of Medical Sciences, Tehran, 
Iran; 
2
Department of Gastroenterology, Gastrointestinal and Liver Diseases Research Center (RCGLD), Shahid Beheshti 
University of Medical Sciences, Tehran, Iran; 
3
Shahid Beheshti University of Medical Sciences, Tehran, Iran; 
4
Department of 
Optometry, Shahid Beheshti University of Medical Sciences, Tehran, Iran; 
5
Infectious Diseases and Tropical Medicine 
Research Center (IDTMRC), Department of Aerospace and Subaquatic Medicine, AJA University of Medical Sciences, 
Tehran, Iran; 
6
Modares Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran 
 
Citation: Gharib A, Forootan M, Sharifzadeh M, Abdi S, 
Darvishi M, Eghbali A. Diagnostic Efficacy of 24-hr 
Esophageal pH Monitoring in Patients with Refractory 
Gastroesophageal Reflux Disease. Open Access Maced J 
Med Sci. https://doi.org/10.3889/oamjms.2018.268 
Keywords: Gastric reflux; PH Impedance; Acid plus acid; 
Diagnosis 
*Correspondence: Mojgan Forootan. Department of 
Gastroenterology, Gastrointestinal and Liver Diseases 
Research Center (RCGLD), Shahid Beheshti University of 
Medical Sciences, Tehran, Iran. E-mail: 
mforootan2003@yahoo.com 
Received: 19-Apr-2018; Revised: 27-May-2018; 
Accepted: 28-May-2018; Online first: 09-Jul-2018  
Copyright: © 2018 Atoosa Gharib, Mojgan Forootan, 
Marjan Sharifzadeh, Saied Abdi, Mohammad Darvishi, 
Ahmad Eghbali. This is an open-access article distributed 
under the terms of the Creative Commons Attribution-
NonCommercial 4.0 International License (CC BY-NC 4.0) 
Funding: This research did not receive any financial 
support 
Competing Interests: The authors have declared that no 
competing interests exist 
 
 
 
 
 
Abstract 
BACKGROUND: Gastric reflux is one of the most important causes of the referral of patients to the internal clinic, 
which in some cases causes problems for patients due to resistance to common treatments. Therefore, timely 
diagnosis and treatment of this group of patients are very important.  
AIM: The purpose of the present study was to determine the off-proton pump inhibitor (off-PPI) 24 h pH-
impedance analyses in patients with refractory gastroesophageal reflux disease (GERD) attending to Taleghani 
Hospital since 2009 to 2017. 
METHODS: In this observational descriptive-comparative off-PPI study, 572 patients with refractory GERD who 
were referred to Taleghani Hospital in Tehran from 2009 to 2017 were selected, and the results of 24 h pH 
Impedance analysis were then assessed. 
RESULTS: The results of 24h pH-impedance indicated that 7% of cases belonged to Pure Acid Reflux followed 
by weakly Acid (1%), non-acid (0.3%), mixed & gas (5.2%), functional (58.4%) and oesophagal hypersensitivity 
(28%). Furthermore, weakly acid plus acid was also found to be 8% and Weakly Acid + Acid + Non-Acid were 
determined as 8.3%. 
CONCLUSIONS: Our findings suggested that nearly more than half of the patients with refractory GERD would 
have a functional disorder in the 24h pH-impedance analysis. 
 
 
 
 
 
 
 
 
Introduction 
 
Reflux or gastroesophageal reflux disease 
(GERD) is one of the common gastrointestinal 
disorders, with many risk factors such as diabetes and 
hypertension [1]. This disorder is present in 16% of 
the general population and can be associated with 
common clinical symptoms, such as heartburn and 
chest pain [2]. However, clinical symptoms in GERD 
patients are not limited to gastrointestinal symptoms 
and can also be manifested as non-gastro-intestinal 
symptoms, including respiratory disorders, sleep 
disturbances, and atorvastinuratory symptoms
 
[3]. The 
disease causes a 2.5-hour absence from the 
workplace, a 23 per cent reduction in efficiency, and a 
30 per cent reduction in the normal performance of 
the individual. In general, there is a significant 
reduction in the quality of life in patients suffering from 
GERD [4]. It also imposes huge costs on individuals 
and health systems [5]. Therefore, treatment for 
GERD patients is important for improving their quality 
of life. Treatment in this area is divided into two 
categories of therapeutic and surgical treatments, 
both of which not only reduce the severity of the 
symptoms of the patients but also significantly 
improve their quality of life [6] [7]. It is worth noting 
that, in both short and long-term, the effectiveness of 
surgical treatments is far more than pharmaceutical 
treatments, and drug therapies are particularly 
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effective on clinical symptoms such as dysphagia 
[6][8]. However, 40% of patients do not show any 
proper therapeutic response, and they refer to 
refractory GERD, which requires the adoption of other 
therapies [9]. The causes of GERD Refractory include 
Acid Reflux, Non-Acid Reflux, Esophageal 
Hypersensitivity, and Functional Heart Burn [10]. 
Moreover, only a few studies have been done in 
Iranian patients [11] [12] [13]. 
On the other hand, GERD is a long-term 
condition in which stomach contents enter the 
oesophagus and cause symptoms or complications. 
Complications include esophagitis, oesophagal 
strictures, and Barrett's oesophagus. There are some 
risk factors involved in the disease, including obesity, 
pregnancy, smoking, hiatus hernia, and taking some 
special medications. Drugs that affect gastric reflux 
are described to be as follow: antihistamines, calcium 
channel blockers, antidepressants and sleep 
medications. Diagnosis among people who do not 
respond in simple ways may be made in other ways, 
such as gastroscopy, oesophagal pH monitoring, and 
or impedance-pH monitoring [13] [14] [15] [16].  
Therefore, the goal of this study was to 
evaluate the causes of refractory GERD in patients 
who referred to Taleghani Hospital from 2009 to 2017 
as off- proton pump inhibitor (off-PPI). 
 
 
Methods 
 
This study was conducted by a descriptive 
cross-sectional study of off-PPI. A total of 572 patients 
with refractory GERD who referred to Tehran 
Taleghani Hospital from 2009 to 2017 were evaluated. 
Endoscopy results and response to medical treatment 
were controlled as interventional factors. In the 
manometer, the absence of motion disorders, such as 
achalasia and diffuse oesophagal spasm (DES), was 
confirmed. 
The required data were extracted from 
patients' files, including the age, sex, duration of 
GERD symptoms, pH and Impedance parameters, 
and symptom association probability (SAP), as well as 
proximal extension and bolus clearance time (BCT). 
Then, the prevalence of different parameters of the 
24h PH Impedance was extracted from them using file 
contents. Finally, data analysis was performed using 
SPSS software version 24. The mean and standard 
deviations were used to evaluate quantitative 
variables, where qualitative variables were presented 
as absolute and relative frequency. The tests used in 
this field included chi-square and analysis of variance. 
The significance level for the relationships between 
variables was considered 0.5. 
 
Inclusion criteria 
Failure of medical treatment with protein 
pumps inhibitors (PPIs) for at least one month, once 
or twice daily [12]. 
 
Exclusion criteria 
1: Patients who had anti-reflux surgery, 
either PPI or H2-blocker. 
2. Patients with atypical GERD 
symptoms. 
3. Motion disorders, such as achalasia 
and diffuse oesophagal spasm.  
4. Non-Iranian patients.  
5. Patients with abnormal manometry. 
 6. Age younger than 18 or over 80 years 
old. 7. Systemic disease. 
 
 
Results 
 
In this study, 572 subjects were studied. Their 
mean age was 38.2 years (range 18-80 years), and 
mean duration of clinical symptoms was 5.1 years 
(from 1 to 16 years). Also, 48.3% were males, and 
51.7% were females. DeMeester Score was abnormal 
in 44.2% of patients and Total Reflux Time in 45.5% 
of patients. The frequency of reflux and the frequency 
of long-term reflux was 40% and 24.1%, respectively. 
In 2.6% of patients, BCT was abnormal and proximal 
extension was observed in 41.8% of subjects. 
Attenuation correction (AC) findings in the upright and 
supine positions were attributed to frequencies of 
20.5% and 25.2%, respectively. Weakly Acid (WA) 
findings in the upright and supine positions were 
abnormal in 50.9% and 49.5% respectively. Abnormal 
Non-Acid (NA) findings in the upright and supine 
positions were observed at 6.3 and 3.3 per cent. 
Mixed findings were abnormal in 61.9% and 65.4%, 
based on the upright and supine positions (Table 1).  
Table 1: Frequency distribution of data based on various 
findings in patients 
  Count Layer N% 
DeMeester Score Abnormal 253 44.2% 
Total Reflux time Abnormal 260 45.5% 
Number of Reflux Abnormal 229 40% 
Number of Long Abnormal 138 24.1% 
Longest Reflux Abnormal 242 42.3% 
BCT Abnormal 15 2.6% 
Proximal Extension Pos 239 41.8% 
Upright AC Abnormal 117 20.5% 
Supine AC Abnormal 144 25.2% 
Upright WA Abnormal 291 50.9% 
Supine WA Abnormal 283 49.5% 
Upright NA Abnormal 36 6.3% 
Supine NA Abnormal 19 3.3% 
Upright Mixed Abnormal 354 61.9% 
Supine Mixed Abnormal 374 65.4% 
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SAP findings were related to the symptoms of 
the patient in 55.8% of the patients, while 30.2% of 
the patients had SAP findings without any association 
with the symptoms of the patient. They were also 
Results in 7% of cases were Pure Acid Reflux 
followed by Weakly Acid (1%), Non-Acid (0.3%), 
Mixed & Gas (5.2%), Functional (58.4%) and 
Esophageal Hypersensitivity (28%). Furthermore, 
Weakly Acid plus Acid was also found to be 8%, and 
Weakly Acid + Acid + Non-Acid were determined as 
8.3% (Table 2). 
Table 2: Frequency of diagnosis in patients 
  Frequency Per cent 
Valid Pure Acid Reflux 40 7 
 Weakly Acid 6 1 
 Non-Acid 2 0.3 
 Mixed&Gas 30 5.2 
 Functional 334 58.4 
 Oesophagal 
Hypersensitivity 
160 28 
 Total 572 100 
 
Analysis of variance (ANOVA) did not show a 
significant difference in the frequency distribution of 
diagnosis based on the age of the patients (P = 
0.216). The frequency distribution of diagnosis did not 
show a significant statistical relationship regarding 
gender-based on chi-square test (P = 0.721). The 
prevalence of functional conditions in men and women 
was revealed to be 59.1 and 57.6%, respectively while 
the cases of hypersensitivity were reported in 27.4% 
of men and 28.6% of women (Table 3). 
Table 3: Distribution of diagnosis based on gender 
  Diagnosis Total 
Pure 
Acid 
Reflux 
Weakly 
Acid 
Non-
Acid 
Mixed&Gas Functional Oesophagal 
Hypersensitivity 
Gender Female 19 
(6.9%) 
2 
(0.7%) 
2 
(0.7%) 
15 (5.4%) 159 
(57.6%) 
79 (28.6%) 276 
(100%) 
 Male 21 
(7.1%) 
4 
(1.4%) 
0 15 (5.1%) 175 
(59.1%) 
81 (27.4%) 296 
(100%) 
Total  40 
(7%) 
6 (1%) 2 
(0.3%) 
30 (5.2%) 334 
(58.4%) 
160 (28%) 572 
(100%) 
 
The frequency of diagnosis showed that the 
duration of symptoms was not statistically significant 
(P = 0.429) based on the ANOVA test. 
 
 
Discussion 
 
In this study, we investigated the various 
causes of GERD refractory in patients who were 
referred to Taleghani patient in Tehran from 2009 to 
2017. All subjects in this study were Off PPI, meaning 
that patients did not take PPI and anti-acid for 2 
weeks before testing. The test results showed that 7% 
of the cases belonged to Pure Acid Reflux based on 
24 h pH-impedance, followed by Weakly Acid (1%), 
Non-Acid (0.3%), Mixed & Gas (5.2%), Functional 
(58.4%) and Esophageal Hypersensitivity (28%). Also, 
Weakly Acid + Acid + Non-Acid cases were found to 
be 8.3%, where is the most common cause of 
refractory cases followed by hypersensitivity, which is 
consistent with other studies in this area
 
[17]. These 
results are consistent with other studies in this area 
[17]. Penagini et al., (2015) evaluated 50 patients with 
refractory GERD in Italy. They determined that 15 of 
the patients (30%) had functional heartburn [18], while 
this rate was about 2 times higher in our research. In 
a cross-sectional study, Frazzoni et al., examined 80 
patients with refractory GERD, 35% of them had 
functional heartburn [19], which was lower than the 
result of our study. In another study, Savarino et al. 
performed an analytical cross-sectional study in Italy 
with 219 patients suffering from refractory GERD that 
39% had functional heartburn [20]. In the present 
study, this was higher which could be due to the 3-fold 
sample size. 
Jung et al., (2007) in the United States, 
assessed 2298 patients with refractory GERD and 
found that 3% of men and 4% of women had suffered 
from functional disorders such as functional heartburn 
[21]. The results of the study are in agreement with 
the results of the current study. In another study by 
Savarino et al., 2009 found that 27% of patients with 
refractory GERD suffered from functional heartburn 
[22], which was half the amount, obtained in our 
study. The higher number of the present study can be 
because of the examination centre as a referral 
hospital. A cross-sectional study by Mohammed Khan 
et al. in 2014 found that almost 60% of patients with 
refractory PPIs NERD and SAP (+) had no acid reflux, 
and about half of nonerosive gastroesophageal reflux 
disease (NERD) patients on PPI had normal 
multichannel intraluminal impedance-pH (MII-pH) 
monitoring, which was equally divided into two groups: 
Functional Heart Burn and hyper-sensitive esophagus 
[23]. We did not find this equal ratio in our study, and 
the frequency of functional cases was higher. 
Herregods et al., reported in an analytical cross-
sectional report that roughly one-third of patients 
referring to GERD symptoms have problems other 
than reflux, the most common of which is Functional 
Heart Burn. This justifies why these patients do not 
benefit from anti-acid therapy [24], and in our study, 
this is proven. Moreover, different studies on various 
subjects have published the regarding the above 
results [25] [26] [27] [28] [29].
 
In conclusion, our data suggest that more 
than half of GERD patients in the 24h pH-impedance 
analysis have functional disorders. Therefore, due to 
the high incidence of functional and hypersensitivity 
cases, we can treat the remaining cases according to 
the prevalence before making expensive and 
inaccessible tests. Taken together, it is recommended 
to use a treatment period for functional and 
hypersensitivity, such as selective serotonin reuptake 
inhibitors (SSRIs) (fluoxetine, etc.).  
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